Drug intelligence / Profile preview

dextroamphetamine saccharate

Development stage
Unknown
Lead developer
Teva Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Dextroamphetamine saccharate is a salt form of dextroamphetamine, the dextrorotatory enantiomer of amphetamine and a centrally acting sympathomimetic stimulant used primarily in mixed amphetamine salt formulations for attention deficit hyperactivity disorder (ADHD) and narcolepsy. As a small-molecule central nervous system stimulant, dextroamphetamine enhances monoaminergic neurotransmission by promoting the release of dopamine and norepinephrine from presynaptic storage vesicles, reversing their transport via dopamine and norepinephrine transporters, and activating trace amine-associated receptor 1, thereby increasing extracellular catecholamine levels in key brain regions involved in attention and wakefulness.[2][3] This saccharate salt is typically used in combination with other dextroamphetamine and amphetamine salts in extended‑release and immediate‑release products, contributing to their overall pharmacokinetic and pharmacodynamic profiles for once‑daily or divided dosing regimens in pediatric and adult patients.[5][10][11]

02

Targets

NET (Norepinephrine Transporter)VMAT2 (Vesicular monoamine transporter 2)TAAR1 (Trace amine-associated receptor 1)DAT (Dopamine plasma membrane transport protein)

Beyond the preview

Go deeper on dextroamphetamine saccharate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dextroamphetamine saccharate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call